EX-21 5 a06-3954_3ex21.htm SUBSIDIARIES OF THE REGISTRANT

Exhibit 21

 

SUBSIDIARIES OF THE COMPANY

 

 

 

State/County of
Incorporation

 

Stock
Ownership

 

 

 

 

 

 

 

West Pharmaceutical Services, Inc

 

Pennsylvania

 

Parent Co.

 

Tech Group, Inc.

 

Arizona

 

100.0

%

Tech Group North America, Inc.

 

Arizona

 

100.0

 

Senetics, Inc.

 

Colorado

 

100.0

 

West Pharmaceutical Services Cleveland, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services Indiana Holding, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services Lakewood, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services Evansville, L.P.

 

Delaware

 

100.0

 

Paco Laboratories, Inc.

 

Delaware

 

100.0

 

Charter Laboratories, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services Canovanas, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services Vega Alta, Inc.

 

Delaware

 

100.0

 

West Pharmaceutical Services of Delaware, Inc.

 

Delaware

 

100.0

 

West Monarch Analytical Laboratories LLC

 

Delaware

 

100.0

 

West Pharmaceutical Services of Florida, Inc.

 

Florida

 

100.0

 

Tech Group Grand Rapids, Inc.

 

Michigan

 

100.0

 

Citation Plastics Co.

 

New Jersey

 

100.0

 

Medimop USA LLC

 

Ohio

 

90.0

(a)

West Pharmaceutical Services Argentina S.A.

 

Argentina

 

100.0

 

West Pharmaceutical Services Australia Pty. Ltd.

 

Australia

 

100.0

 

West International Sales Corporation

 

Barbados

 

100.0

 

West Pharmaceutical Services Brasil LTDA.

 

Brasil

 

100.0

 

West Pharmaceutical Services Colombia S.A.

 

Colombia

 

98.2

(b)

West Pharmaceutical Services Holding Danmark ApS

 

Denmark

 

100.0

 

West Pharmaceutical Services Danmark A/S

 

Denmark

 

100.0

 

West Pharmaceutical Services Finance Danmark ApS

 

Denmark

 

100.0

 

West Pharmaceutical Services Limited Danmark A/S

 

Denmark

 

100.0

 

West Pharmaceutical Services Group Limited

 

England

 

100.0

 

West Pharmaceutical Services Drug Delivery & Clinical Research Centre Ltd.

 

England

 

100.0

 

West Pharmaceutical Services Cornwall Ltd.

 

England

 

100.0

 

Plasmec PLC

 

England

 

100.0

 

West Pharmaceutical Services Lewes Ltd.

 

England

 

100.0

 

West Pharmaceutical Services Dublin, Ltd.

 

England

 

100.0

 

West Pharmaceutical Services France S.A.

 

France

 

99.9

(c)

West Pharmaceutical Services Holding France SAS

 

France

 

100.0

 

West Pharmaceutical Services Holding GmbH

 

Germany

 

100.0

 

West Pharmaceutical Services Verwaltungs GmbH

 

Germany

 

100.0

 

West Pharmaceutical Services Deutschland GmbH Co KG

 

Germany

 

100.0

 

The West Company (India) Private Ltd.

 

India

 

100.0

 

Tech Group Ireland

 

Ireland

 

100.0

 

Medimop Projects North – Israel

 

Israel

 

90.0

(a)

Medimop – Israel

 

Israel

 

90.0

(a)

West Pharmaceutical Services Italia S.r.L.

 

Italy

 

100.0

 

The West Company (Mauritius) Ltd.

 

Mauritius

 

100.0

 

Tech Group de Mexico SRL de CV

 

Mexico

 

100.0

 

(MFG) Tech Group Puerto Rico, Inc.

 

Puerto Rico

 

100.0

 

West Pharmaceutical Services Singapore Pte. Ltd

 

Singapore

 

100.0

 

West Pharmaceutical Services Hispania S.A.

 

Spain

 

100.0

 

West Pharmaceutical Services Venezuela C.A.

 

Venezuela

 

100.0

 

Pharma-Gummi Beograd

 

Yugoslavia

 

100.0

 

 


(a) 10% is owned directly by the previous owner

(b) 1.55% is held in treasury by West Pharmaceutical Services Colombia S.A.

(c) In addition, .01% is owned directly by 8 individual shareholders who are officers of the Company